What are the causes and treatment options for hypercalcemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Hypercalcemia

Primary hyperparathyroidism and malignancy account for over 90% of all hypercalcemia cases, with the remaining causes including granulomatous diseases, endocrinopathies, medications, and vitamin D disorders. 1, 2

Major Causes

Primary Hyperparathyroidism (PHPT)

  • PHPT is characterized by elevated or inappropriately normal PTH levels in the setting of hypercalcemia, typically with serum calcium <12 mg/dL and a chronic course lasting >6 months. 3, 2
  • Associated findings include hypophosphatemia, hyperchloremic metabolic acidosis, kidney stones, and metabolic bone disease (osteitis fibrosa cystica), but notably no anemia. 3, 2
  • This represents one of the two most common causes and tends to present with milder, more subtle symptoms compared to malignancy-related hypercalcemia. 2

Malignancy-Associated Hypercalcemia (MAH)

  • Malignancy causes hypercalcemia through four distinct mechanisms: PTHrP-mediated humoral hypercalcemia (most common), osteolytic bone metastases, 1,25-vitamin D production (lymphomas), and rarely ectopic PTH secretion. 3, 4
  • Characterized by rapid onset over days to weeks, higher calcium levels (often >12 mg/dL), suppressed PTH (<20 pg/mL), marked anemia, and absence of kidney stones or metabolic acidosis. 3, 2, 4
  • PTHrP is elevated in many solid tumors, particularly squamous cell carcinomas and renal cell carcinoma. 3
  • Carries a poor prognosis with median survival of approximately 1 month. 5

Granulomatous Diseases

  • Sarcoidosis and other granulomatous disorders cause hypercalcemia through excessive production of 1,25-dihydroxyvitamin D by activated macrophages, leading to increased intestinal calcium absorption. 3, 1
  • Characterized by elevated 1,25-dihydroxyvitamin D levels with suppressed PTH. 3
  • Responds specifically to glucocorticoid therapy. 6, 1

Vitamin D-Related Disorders

  • Vitamin D intoxication causes hypercalcemia through excessive intestinal calcium absorption, with elevated 25-hydroxyvitamin D levels (intoxication) or elevated 1,25-dihydroxyvitamin D (granulomatous disease/lymphoma). 3, 1
  • Vitamin D supplements should be avoided in all patients with active hypercalcemia. 6, 5

Endocrinopathies

  • Thyroid disease and other endocrine disorders account for a small percentage of hypercalcemia cases. 1

Medication-Induced Hypercalcemia

  • Thiazide diuretics, calcium supplements, vitamin A supplements, lithium, and denosumab discontinuation can all cause hypercalcemia. 1
  • Sodium-glucose cotransporter 2 inhibitors and immune checkpoint inhibitors are emerging causes but account for <1% of cases. 1

Genetic and Familial Disorders

  • Williams syndrome is associated with idiopathic infantile hypercalcemia, most common in the first 2 years of life, with abnormal calcium and vitamin D metabolism that may persist lifelong. 7
  • Presents with extreme irritability, vomiting, constipation, muscle cramps, and risk of nephrocalcinosis. 7

Immobilization

  • Prolonged bed rest reduces bone formation and increases bone resorption, leading to hypercalcemia, particularly in patients with high bone turnover. 1, 8

Rare Causes (<1% of cases)

  • SARS-CoV-2 infection, ketogenic diets, and extreme exercise have been associated with hypercalcemia. 1

Diagnostic Approach to Determine Etiology

Measure intact PTH first—this single test distinguishes PTH-dependent from PTH-independent causes and guides all subsequent workup. 3, 1

PTH Elevated or Inappropriately Normal (PTH-Dependent)

  • Diagnosis: Primary hyperparathyroidism or familial hypocalciuric hypercalcemia. 3, 2
  • Confirm with hypophosphatemia and hyperchloremic metabolic acidosis. 3

PTH Suppressed (<20 pg/mL) (PTH-Independent)

  • Measure PTHrP, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, phosphorus, and magnesium to differentiate among malignancy, vitamin D disorders, and granulomatous disease. 5, 3
  • Elevated PTHrP indicates malignancy (humoral mechanism). 3
  • Elevated 1,25-dihydroxyvitamin D with normal 25-hydroxyvitamin D suggests granulomatous disease or lymphoma. 3
  • Elevated 25-hydroxyvitamin D indicates vitamin D intoxication. 3

Critical Pitfall to Avoid

  • Always rule out pseudo-hypercalcemia by measuring ionized calcium or correcting total calcium for albumin using the formula: Corrected calcium (mg/dL) = Total calcium (mg/dL) - 0.8 × [Albumin (g/dL) - 4]. 3, 9
  • Pseudo-hypercalcemia results from hemolysis or improper blood sampling and does not require treatment. 7

References

Research

Hypercalcemia: A Review.

JAMA, 2022

Research

Hypercalcemia: an evidence-based approach to clinical cases.

Iranian journal of kidney diseases, 2009

Guideline

Hypercalcemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hypercalcemia of Malignancy: An Update on Pathogenesis and Management.

North American journal of medical sciences, 2015

Guideline

Treatment of Hypercalcemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Hypercalcemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of hypercalcemia.

Endocrinology and metabolism clinics of North America, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.